Experts share the common evening habits that may be working against your cholesterol goals, plus what to do instead.

I encourage people to focus on those you can control—such as what you eat and how active you are—and do the best you can to ...

Cardiologists explain the biggest misconception around heart health, and why waiting for symptoms is "the wrong strategy." ...

Eli Lilly's triple G agonist retatrutide has achieved weight loss of more than 28% in a new phase 3 trial that keeps it on ...

Just taking a small amount of time out of your day for this could have a positive effect ...

A new experimental weight-loss drug called Retatrutide helped people lose up to 85 pounds in clinical trials. Experts say the ...

A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity, ...

Retatrutide helped people lose 70 pounds on average, or 28% of their body weight, in a clinical trial. The Eli Lilly weight-loss drug mimics three gut hormones.

Retatrutide by Eli Lilly is a once-weekly medicine that can lower food intake, improve glucose control, and increase calorie ...

While retatrutide may have the best weight loss efficacy to date, analysts hold concerns about its tolerability profile compared with best-seller, tirzepatide.

Eli Lilly's retatrutide delivers its third phase III win, showing up to 28.3% weight loss at 80 weeks and broader gains ...

People with good physical fitness in their 30s and 50s have more elastic arteries later in life. This is shown in a new study from Karolinska Institutet, published in the journal Scientific Reports, ...